Logotype for Shenzhen Capchem Technology Co Ltd

Shenzhen Capchem Technology (300037) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Shenzhen Capchem Technology Co Ltd

Q2 2024 earnings summary

13 Jun, 2025

Executive summary

  • Revenue for H1 2024 reached ¥3.58 billion, up 4.35% year-over-year; net profit attributable to shareholders was ¥416 million, down 19.54% year-over-year.

  • Operating cash flow was negative at -¥257 million, a significant decrease from the prior year.

  • The company maintained its position as a leading supplier in battery chemicals, organic fluorine chemicals, capacitor chemicals, and semiconductor chemicals.

  • The board approved a cash dividend of ¥6 per 10 shares for 2023, with no interim dividend for H1 2024.

  • Major new supply agreements and overseas expansion projects were announced, supporting future growth.

Financial highlights

  • H1 2024 revenue: ¥3.58 billion (+4.35% YoY); net profit: ¥416 million (-19.54% YoY); EPS: ¥0.55 basic, ¥0.50 diluted.

  • Gross margin for the chemical segment: 27.88% (-3.07pp YoY); battery chemicals margin: 13.65% (-2.08pp YoY); organic fluorine margin: 62.22% (-10.17pp YoY); capacitor chemicals margin: 40.48% (+2.14pp YoY).

  • Operating cash flow: -¥257 million (vs. +¥1.61 billion YoY); total assets: ¥16.58 billion (-5.93% vs. end-2023).

  • R&D investment: ¥216 million (+24.98% YoY); overseas sales accounted for 25.8% of total revenue.

  • EBITDA/total debt: 11.04%; interest coverage: 11.02x; asset-liability ratio: 41.38%.

Outlook and guidance

  • Management expects continued growth in global lithium battery demand, with battery chemicals and high-end fluorine products as key drivers.

  • Ongoing overseas expansion (notably in Europe and the US) and new long-term supply contracts are expected to boost future revenue.

  • The company will focus on R&D, cost control, and operational efficiency to address margin pressure.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more